Neupath Health Inc. (NPTH) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

joining us this morning for New Paths Q3 results. The company will be making a presentation and discussing their business and their financial results. And then we will be taking questions from the audience. So please type your questions into the Zoom Q&A. function, and I will read those out to management. Please try to keep the questions clear and tight. It makes everything a lot better. Sometimes it's literally hard to understand what the question is. And with that, we're gonna get the show officially on the go here. NewPath is Canada's largest provider of health care services for the treatment and assessment of chronic pain, back injuries, sports-related injuries, and concussions. The company just released its Q3 results with over 26% revenue growth and adjusted EBITDA up 98%. CEO Joe Wolowitz and Stephen Lemieux, the president, are here to discuss the results. I'm Martin Gagel with Market Radius Research. Please remember, this is neither a recommendation nor investment advice. Gentlemen, welcome back and congrats on another strong quarter. Thanks, Martin, and thanks for the intro there. I'm Joe Wolowitz. I'm the CEO of New Path Health, and I'm joined here by Stephen Lemieux, our president. And I apologize for those of you who know the story, I'm going to go over a little bit just background. So for those who are new to the story can get a little sense of what we do. So as Martin mentioned, we are Canada's largest network of chronic pain treatment facilities. Next slide, Martin. We will be making forward-looking statements today. I encourage all investors to have a look at our AIF and all our other documents filed on CDAR. We do also use non-IFRS measures. And just so everyone knows, all our details are in the financials and there's nothing, everything's there. And...